KC QVIC: Improving Transitions of Care for Heart Failure

Wednesday Nov 4 / 3:00 PM (CDT) - Wednesday Nov 4 / 4:30 PM (CDT)

Register Now

Virtual
-
Kansas City, MO

KC QVIC: Improving Transitions of Care for Heart Failure

3:00pm-3:05pm: Welcome & Introduction Stacy Farr, PhD, MPH; KC Quality & Value Innovation Consortium (KC QVIC); University of Missouri Kansas City; Saint Luke’s Health System (SLHS)

3:05-3:20pm: Challenges in Reducing Heart Failure Readmissions: Lessons from BEAT-HF and Current Thinking on Whether they Can They Be Effectively and Safety Reduced Gregg Fonarow, MD; Eliot Corday Professor of Cardiovascular Medicine & Science; Director, Ahmanson-UCLA Cardiomyopathy Center; Co-Director, UCLA Preventative Cardiology Program; Interim Chief, UCLA Division of Cardiology; David Geffen School of Medicine, UCLA

3:20-3:35pm: Current Thinking on Innovations to Improve Transitions of Care for Heart Failure Patients and the Role of Learning Healthcare Systems Adrian Hernandez, MD, MHS; Executive Director; Duke Clinical Research Institute; Vice Dean, Duke University School of Medicine

3:35-3:45pm: Questions for Drs. Fonarow and Hernandez

3:45 to 3:50 pm Regional QVIC Project Perspective: Overview of the Transitions of Care for Heart Failure Project – Paul Chan, MD; Cardiologist, Saint Luke’s Health System and Professor, University of Missouri, Kansas City

3:50-4:00 pm: Improving Outcomes for Heart Failure Patients: Lessons From Emergency Department Initiated CodeHF –John Spertus, MD, MPH; KC Quality & Value Innovation Consortium (KC QVIC); University of Missouri Kansas City; Saint Luke’s Health System (SLHS) ….&/or Vittal Hejjaji, MD; Fellow; KC Quality & Value Innovation Consortium (KC QVIC); University of Missouri Kansas City; Saint Luke’s Health System (SLHS)

4:00-4:10 pm: Addressing Social Determinants of Health with Managed Services Network in Kansas City – Paul Chan, MD; Cardiologist, Saint Luke’s Health System and Professor, University of Missouri, Kansas City

4:10-4:20 pm: Implementing & Evaluating the Coordinated Payer Disease Management Programs in Kansas City –Mary Benton PhD, MA; T32 Cardiovascular Outcomes Research Fellow; Kansas City Quality & Value Innovation Consortium (KC QVIC); and Mark Patterson, Ph.D., MPH; Associate Professor at UMKC School of Pharmacy; Kansas City Quality & Value Innovation Consortium (KC QVIC)

4:20-4:30pm: Questions, Discussion, & Wrap-Up

Share:

Interested in Getting more involved with BioNexus KC and our events?